An Assessment of Ustekinumab Immunogenicity in Perianal Crohn's Disease

被引：0
|
作者：
Manski, Scott [1 ]
Dioguardi, Vincent [1 ]
Weil, Blake J. [1 ]
Edirisuriya, Chelsea [1 ]
Shivashankar, Raina [1 ]
机构：
[1] Thomas Jefferson Univ Hosp, Philadelphia, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2023年 / 118卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1116
引用
收藏
页码：S848 / S849
页数：2
相关论文
共 50 条
  • [1] An Assessment of Vedolizumab Immunogenicity in Perianal Crohn's Disease
    Manski, Scott
    Edirisuriya, Chelsea
    Fabrizio, Joseph
    Dioguardi, Vincent
    Shivashankar, Raina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S848 - S848
  • [2] Ustekinumab and remission in perianal Crohn's disease: A case report
    Alcantara-Figueroaa, C. E.
    Coronado-Rivera, E. F.
    Estela-Vasquezb, E. F.
    Calderon-Cabreraa, D. C.
    Alcantara-Ascon, R. A.
    REVISTA DE GASTROENTEROLOGIA DE MEXICO, 2023, 88 (04): : 431 - 432
  • [3] Efficacy of Ustekinumab Therapy in Patients With Perianal Crohn's Disease
    Manski, Scott
    Dioguardi, Vincent
    Weil, Blake J.
    Edirisuriya, Chelsea
    Gandhi, Hema K.
    Shivashankar, Raina
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S847 - S847
  • [4] Ustekinumab for the treatment of perianal fistulas in patients with Crohn's disease
    Battat, R.
    Bessissow, T.
    Strohl, M.
    Kopylov, U.
    Bitton, A.
    Cohen, A.
    Seidman, E.
    Afif, W.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S400 - S401
  • [5] USTEKINUMAB FOR THE TREATMENT OF PERIANAL FISTULAS IN PATIENTS WITH CROHN'S DISEASE
    Battat, Robert
    Bessissow, Talat
    Strohl, Matthew
    Kopylov, Uri
    Bitton, Alain
    Cohen, Albert
    Seidman, Ernest G.
    Afif, Waqqas
    GASTROENTEROLOGY, 2017, 152 (05) : S407 - S407
  • [6] A PILOT STUDY ON THE USE OF USTEKINUMAB IN REFRACTORY PERIANAL CROHN'S DISEASE
    Crispino, F.
    Brinch, D.
    Busacca, A.
    Carrozza, L.
    Cocorullo, G.
    Cappello, M.
    DIGESTIVE AND LIVER DISEASE, 2021, 53 : S164 - S164
  • [7] Ustekinumab achieves good clinical Results for perianal Crohn's Disease
    Di Lellis, Maddalena Angela
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (02): : 104 - 104
  • [8] Ustekinumab for Perianal Crohn's Disease: The BioLAP Multicenter Study From the GETAID
    Chapuis-Biron, Constance
    Kirchgesner, Julien
    Pariente, Benjamin
    Bouhnik, Yoram
    Amiot, Aurelien
    Viennot, Stephanie
    Serrero, Melanie
    Fumery, Mathurin
    Allez, Matthieu
    Siproudhis, Laurent
    Buisson, Anthony
    de Chambrun, Guillaume Pineton
    Abitbol, Vered
    Nancey, Stephane
    Caillo, Ludovic
    Plastaras, Laurianne
    Savoye, Guillaume
    Chanteloup, Elise
    Simon, Marion
    Dib, Nina
    Rajca, Sylvie
    Amil, Morgane
    Parmentier, Anne-Laure
    Peyrin-Biroulet, Laurent
    Vuitton, Lucine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (11): : 1812 - 1820
  • [9] Assessment of perianal disease activity in patients with Crohn's disease
    Losco, Alessandra
    Vigano, Chiara
    Conte, Dario
    Cesana, Bruno M.
    Basilisco, Guido
    GASTROENTEROLOGY, 2007, 132 (04) : A360 - A360
  • [10] High Immunogenicity to Influenza Vaccination in Crohn's Disease Patients Treated with Ustekinumab
    Doornekamp, Laura
    Goetgebuer, Rogier L.
    Schmitz, Katharina S.
    Goeijenbier, Marco
    van der Woude, C. Janneke
    Fouchier, Ron
    van Gorp, Eric C. M.
    de Vries, Annemarie C.
    VACCINES, 2020, 8 (03) : 1 - 16
12345